Asha S. Multani
0000-0002-6989-8627
Publication & Citation Trends
Publications
0 total
Abstract PS13-07: Enhancing T-DXd Efficacy in HER2-positive Breast Cancer Resistant to HER2 ADC by Non-biased Kinase-related Target Screening
Cited by 0
Semantic Scholar
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response OA
Cited by 40
Semantic Scholar
Normal breast tissues harbour rare populations of aneuploid epithelial cells
Cited by 27
Semantic Scholar
Low Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer.
Cited by 9
Semantic Scholar
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer OA
Cited by 20
Semantic Scholar
Abstract 308: Low molecular weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer
Cited by 0
Semantic Scholar
Abstract 2585: Mutant p53 gains oncogenic functions through a cytosolic DNA response
Cited by 0
Semantic Scholar
Research Topics
Cancer-related Molecular Pathways
(38)
Cancer Genomics and Diagnostics
(36)
Telomeres, Telomerase, and Senescence
(35)
DNA Repair Mechanisms
(27)
Cancer Research and Treatments
(24)
Affiliations
Gujarat University
Fox Chase Cancer Center
Cleveland Clinic
The University of Texas MD Anderson Cancer Center
Harvard University